‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Neurology Today in 5
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
30
00:00:00
/ 00:06:07
30